Pediatric Non-Hodgkin's Lymphoma

Overview

Journal Curr Oncol Rep

Publisher Current Science

Specialty Oncology

Date 2007 Nov 10

PMID 17991353

Citations 12

Authors

Thomas G Gross

Amanda M Termuhlen

Affiliations

Soon will be listed here.

Abstract

Non-Hodgkin's lymphoma (NHL) accounts for 7% of cancer in children and adolescents in the United States, or approximately 1000 cases annually. NHL in the pediatric population differs from that observed in adult patients with respect to staging systems, histologic subtypes of disease, treatment, and outcomes. Although more than 90% of pediatric NHL is of high-grade histology, more than 80% of patients achieve long-term event-free survival with modern therapy. This review focuses on current treatments for pediatric NHL and some of the differences between NHL observed in pediatric and adult patients.

Citing Articles

Childhood Malignancies-Clinico-demographic Profile of Patients Attending the Department of Otorhinolaryngology at a Tertiary Care Centre in North-East India.

Sharma K, Goswami A Indian J Otolaryngol Head Neck Surg. 2023; 75(3):2006-2016.

PMID: 37636808 PMC: 10447731. DOI: 10.1007/s12070-023-03779-1.

Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review.

Daetwyler E, Bargetzi M, Otth M, Scheinemann K BMC Cancer. 2022; 22(1):267.

PMID: 35287628 PMC: 8919635. DOI: 10.1186/s12885-021-09145-0.

Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients.

Lu S, Zhu X, Li W, Chen H, Zhou D, Zhen Z Front Oncol. 2021; 11:598226.

PMID: 33718146 PMC: 7953141. DOI: 10.3389/fonc.2021.598226.

Antibody therapies for lymphoma in children.

de Zwart V, Gouw S, Meyer-Wentrup F Cochrane Database Syst Rev. 2016; (1):CD011181.

PMID: 26784573 PMC: 8719646. DOI: 10.1002/14651858.CD011181.pub2.

Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt.

Sherief L, Elsafy U, Abdelkhalek E, Kamal N, Youssef D, Elbehedy R Mol Clin Oncol. 2014; 3(1):139-144.

PMID: 25469284 PMC: 4251264. DOI: 10.3892/mco.2014.425.

References

Rosh J, Gross T, Mamula P, Griffiths A, Hyams J . Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?. Inflamm Bowel Dis. 2007; 13(8):1024-30. DOI: 10.1002/ibd.20169. View

Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G . Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 2001; 97(12):3699-706. DOI: 10.1182/blood.v97.12.3699. View

Kumar S, Pittaluga S, Raffeld M, Guerrera M, Seibel N, Jaffe E . Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. Pediatr Dev Pathol. 2005; 8(1):52-60. DOI: 10.1007/s10024-004-8087-6. View

Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K . Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 2003; 21(9):1782-9. DOI: 10.1200/JCO.2003.08.151. View

Brugieres L, Quartier P, Le Deley M, Pacquement H, Perel Y, Bergeron C . Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology. Ann Oncol. 2000; 11(1):53-8. DOI: 10.1023/a:1008352726155. View

Oschlies I, Klapper W, Zimmermann M, Krams M, Wacker H, Burkhardt B . Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood. 2006; 107(10):4047-52. DOI: 10.1182/blood-2005-10-4213. View

Dave S, Fu K, Wright G, Lam L, Kluin P, Boerma E . Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006; 354(23):2431-42. DOI: 10.1056/NEJMoa055759. View

Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K . CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006; 7(5):379-91. DOI: 10.1016/S1470-2045(06)70664-7. View

Seidemann K, Tiemann M, Henze G, Sauerbrey A, Muller S, Reiter A . Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Med Pediatr Oncol. 1999; 33(6):536-44. DOI: 10.1002/(sici)1096-911x(199912)33:6<536::aid-mpo3>3.0.co;2-z. View

10.

Sabesan V, Cairo M, Lones M, Perkins S, Morris E, Sposto R . Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers. J Pediatr Hematol Oncol. 2003; 25(2):109-13. DOI: 10.1097/00043426-200302000-00005. View

11.

Carbone P, Kaplan H, MUSSHOFF K, SMITHERS D, TUBIANA M . Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31(11):1860-1. View

12.

Reiter A, Schrappe M, Ludwig W, Tiemann M, Parwaresch R, Zimmermann M . Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000; 95(2):416-21. View

13.

Sandlund J, Downing J, Crist W . Non-Hodgkin's lymphoma in childhood. N Engl J Med. 1996; 334(19):1238-48. DOI: 10.1056/NEJM199605093341906. View

14.

Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M, Reutzel R . Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 2002; 99(12):4379-85. DOI: 10.1182/blood-2002-01-0110. View

15.

Coustan-Smith E, Sancho J, Hancock M, Razzouk B, Ribeiro R, Rivera G . Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia. Blood. 2002; 100(7):2399-402. DOI: 10.1182/blood-2002-04-1130. View

16.

Duyster J, Bai R, Morris S . Translocations involving anaplastic lymphoma kinase (ALK). Oncogene. 2001; 20(40):5623-37. DOI: 10.1038/sj.onc.1204594. View

17.

Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999; 17(12):3835-49. DOI: 10.1200/JCO.1999.17.12.3835. View

18.

Mounier N, Briere J, Gisselbrecht C, Emile J, Lederlin P, Sebban C . Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood. 2003; 101(11):4279-84. DOI: 10.1182/blood-2002-11-3442. View

19.

MURPHY S, Fairclough D, Hutchison R, BERARD C . Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989; 7(2):186-93. DOI: 10.1200/JCO.1989.7.2.186. View

20.

Laver J, Kraveka J, Hutchison R, Chang M, Kepner J, Schwenn M . Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III.... J Clin Oncol. 2005; 23(3):541-7. DOI: 10.1200/JCO.2005.11.075. View